臨床眼科69巻2号

2015年02月発行

連載 今月の話題

培養角膜内皮細胞移植

著者： 小泉範子¹

所属機関： ¹同志社大学生命医科学部医工学科・京都府立医科大学視覚機能再生外科学

ページ範囲：P.129 - P.135

　水疱性角膜症に対する新しい治療法として，生体外で培養した角膜内皮細胞を用いた再生医療が注目されている。筆者らの研究チームでは，高品質なヒト角膜内皮細胞を効率的に増殖させる培養技術を確立し，サルを用いた前臨床研究を経て，2013年に京都府立医科大学において培養角膜内皮細胞の前房注入治療の臨床研究を開始した。これまでの研究開発の経緯と角膜内皮治療の将来展望を述べる。

参考文献

1）木下　茂・天野史郎・井上幸次・他：角膜内皮障害の重症度分類．日眼会誌　118：81-83，2014

2）Nakagawa H, Inatomi T, Hieda O et al：Clinical outcomes in Descemet stripping automated endothelial keratoplasty with internationally shipped precut donor corneas. Am J Ophthalmol　157：50-55, 2014

3）小泉範子・西田幸二・天野史郎・他：日本における角膜再生医療の現状．日眼会誌　111：493-503，2007

4）Ishino Y, Sano Y, Nakamura T et al：Amniotic membrane as a carrier for cultivated human corneal endothelial cell transplantation. Invest Ophthalmol Vis Sci　45：800-806, 2004

5）Mimura T, Yamagami S, Yokoo S et al：Cultured human corneal endothelial cell transplantation with a collagen sheet in a rabbit model. Invest Ophthalmol Vis Sci　45：2992-2997, 2004

6）Ide T, Nishida K, Yamato M et al：Structural characterization of bioengineered human corneal endothelial cell sheets fabricated on temperature-responsive culture dishes. Biomaterials　27：607-614, 2006

7）Sumide T, Nishida K, Yamato M et al：Functional human corneal endothelial cell sheets harvested from temperature-responsive culture surfaces. Faseb J　20：392-394, 2006

8）Koizumi N, Sakamoto Y, Okumura N et al：Cultivated corneal endothelial cell sheet transplantation in a primate model. Invest Ophthalmol Vis Sci　48：4519-4526, 2007

9）Koizumi N, Sakamoto Y, Okumura N et al：Cultivated corneal endothelial transplantation in a primate. Possible clinical application in corneal endothelial regenerative medicine. Cornea　27：S48-55, 2008

10）Koizumi N, Okumura N, Kinoshita S：Development of new therapeutic modalities for corneal endothelial disease focused on the proliferation of corneal endothelial cells using animal models. Exp Eye Res　95：60-67, 2012

11）Watanabe K, Ueno M, Kamiya D et al：A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol　25：681-686, 2007

12）Okumura N, Ueno M, Koizumi N et al：Enhancement of primate corneal endothelial cell survival in vitro by a ROCK inhibitor. Invest Ophthalmol Vis Sci　50：3680-3687, 2009

13）Nakahara M, Okumura N, Kay EP et al：Corneal endothelial expansion promoted by human bone marrow mesenchymal stem cell-derived conditioned medium. PLoS One　8：e69009, 2013

14）Okumura N, Kay EP, Nakahara M et al：Inhibition of TGF-beta signaling enables human corneal endothelial cell expansion in vitro for use in regenerative medicine. PLoS One　8：e58000, 2013

15）Okumura N, Koizumi N, Ueno M et al：ROCK inhibitor converts corneal endothelial cell into a phenotype capable of regenerating in vivo endothelial tissue. Am J Pathol　181：268-277, 2012

16）Okumura N, Koizumi N, Ueno M et al：Enhancement of corneal endothelium wound healing by a ROCK inhibitor eye drop. Br J Ophthalmol　95：1006-1009, 2011

17）Okumura N, Koizumi N, Ueno M et al：The new therapeutic concept of using a rho kinase inhibitor for the treatment of corneal endothelial dysfunction. Cornea　30：S54-59, 2011

18）Okumura N, Nakano S, Kay EP et al：Involvement of cyclin D and p27 in cell proliferation mediated by ROCK Inhibitors Y-27632 and Y-39983 during corneal endothelium wound healing. Invest Ophthalmol Vis Sci　55：318-329, 2014

19）Okumura N, Koizumi N, Kay EP et al：The ROCK inhibitor eye drop accelerates corneal endothelium wound healing. Invest Ophthalmol Vis Sci　54：2493-2502, 2013

20）Koizumi N, Okumura N, Ueno M et al：Rho-associated kinase inhibitor eye drop treatment as a possible medical treatment for Fuchs corneal dystrophy. Cornea　32：1167-1170, 2013